Our top pick for
Finder may earn compensation from partners, but editorial opinions are our own. Advertiser Disclosure
Aspira Women's Health Inc is a diagnostics & research business based in the US. Aspira Womens Health shares (AWH) are listed on the NASDAQ and all prices are listed in US Dollars.
|Latest market close||$3.22|
|52-week range||$2.98 - $10.54|
|50-day moving average||$3.40|
|200-day moving average||$4.78|
|Wall St. target price||$12.00|
|Dividend yield||N/A (0%)|
|Earnings per share (TTM)||$-0.22|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-10-14)||4.55%|
|1 month (2021-09-21)||-7.74%|
|3 months (2021-07-21)||-35.47%|
|6 months (2021-04-21)||-45.24%|
|1 year (2020-10-21)||-12.50%|
|2 years (2019-10-21)||507.55%|
|3 years (2018-10-19)||577.75%|
|5 years (2016-10-21)||190.09%|
|Revenue TTM||$6 million|
|Gross profit TTM||$1.2 million|
|Return on assets TTM||-44.1%|
|Return on equity TTM||-86.36%|
|Market capitalisation||$351.9 million|
TTM: trailing 12 months
There are currently 9.8 million Aspira Womens Health shares held short by investors – that's known as Aspira Womens Health's "short interest". This figure is 7.6% down from 10.6 million last month.
There are a few different ways that this level of interest in shorting Aspira Womens Health shares can be evaluated.
Aspira Womens Health's "short interest ratio" (SIR) is the quantity of Aspira Womens Health shares currently shorted divided by the average quantity of Aspira Womens Health shares traded daily (recently around 517791.3938754). Aspira Womens Health's SIR currently stands at 18.94. In other words for every 100,000 Aspira Womens Health shares traded daily on the market, roughly 18940 shares are currently held short.
However Aspira Womens Health's short interest can also be evaluated against the total number of Aspira Womens Health shares, or, against the total number of tradable Aspira Womens Health shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Aspira Womens Health's short interest could be expressed as 0.09% of the outstanding shares (for every 100,000 Aspira Womens Health shares in existence, roughly 90 shares are currently held short) or 0.1697% of the tradable shares (for every 100,000 tradable Aspira Womens Health shares, roughly 170 shares are currently held short).
A SIR above 10% would generally be considered pretty high, pointing to a potentially pessimistic outlook for the share price and a discouraging interest in betting against Aspira Womens Health.
Find out more about how you can short Aspira Womens Health stock.
We're not expecting Aspira Womens Health to pay a dividend over the next 12 months.
Aspira Womens Health's shares were split on a 1:10 basis on 3 March 2008. So if you had owned 10 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Aspira Womens Health shares – just the quantity. However, indirectly, the new 900% higher share price could have impacted the market appetite for Aspira Womens Health shares which in turn could have impacted Aspira Womens Health's share price.
Over the last 12 months, Aspira Womens Health's shares have ranged in value from as little as $2.98 up to $10.54. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Aspira Womens Health's is 3.046. This would suggest that Aspira Womens Health's shares are significantly more volatile than the average for this exchange and represent a higher risk.
Aspira Women's Health Inc. , together with its subsidiaries, discovers, develops, and commercializes diagnostic and bio-analytical solutions that help physicians to diagnose, treat, and enhance gynecologic health outcomes for women in the United States. It provides OVA1, Overa, and Ova1PLUS to detect the risk of ovarian malignancy. The company also offers ASPiRA GenetiX, a genetic test for the risk of gynecologic cancer. In addition, it owns and operates ASPiRA LABS, a lab that specializes in applying biomarker-based technologies to address critical needs in the management of gynecologic cancers and disease. Further, the company is developing diagnostic algorithms; and a high-risk screening algorithm for patients who are genetically predisposed to ovarian cancer. It has entered into a collaborative research agreement with Baylor Genetics to co-develop a novel ovarian cancer early-detection test; and an agreement with Dana Farber Cancer Institute, Brigham and Women's Hospital, and Medical University Lodz to evaluate the microRNA technology in combination with Aspira technologies for the development of an early detection test for ovarian cancer.
Steps to owning and managing ProShares Bitcoin Strategy ETF units.
Everything we know about the The Real Good Food Company IPO, plus information on how to buy in.
Everything we know about the Lulu’s Fashion Lounge Holdings IPO, plus information on how to buy in.
Everything we know about the Allarity Therapeutics IPO, plus information on how to buy in.
Everything we know about the Jupiter Neurosciences IPO, plus information on how to buy in.
Everything we know about the Mainz Biomed IPO, plus information on how to buy in.
Everything we know about the Progressive Care IPO, plus information on how to buy in.
Everything we know about the Desert Peak Minerals IPO, plus information on how to buy in.
Everything we know about the Vaxxinity IPO, plus information on how to buy in.
Everything we know about the Entrada Therapeutics IPO, plus information on how to buy in.
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.